1. Hepatobiliary and Pancreatic: Biliary injury related to checkpoint inhibitor "pembrolizumab". Issue 9 (14th June 2019) Authors: Kida, A; Matsuda, K; Matsuda, M; Sakai, A Journal: Journal of gastroenterology and hepatology Issue: Volume 34:Issue 9(2019) Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗